Related references
Note: Only part of the references are listed.Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling
Youngwook Ahn et al.
DEVELOPMENT (2013)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lrp5 functions in bone to regulate bone mass
Yajun Cui et al.
NATURE MEDICINE (2011)
Sclerosteosis - An autosomal recessive disorder
Peter Beighton et al.
CLINICAL GENETICS (2010)
Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning
Youngwook Ahn et al.
DEVELOPMENT (2010)
BMP-2 Modulates β-Catenin Signaling Through Stimulation of Lrp5 Expression and Inhibition of β-TrCP Expression in Osteoblasts
Ming Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Vijay K. Yadav et al.
CELL (2008)
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling
Wendy Balemans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Structure-based mutation analysis shows the importance of LRP5 β-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling
Bheem M. Bhat et al.
GENE (2007)
Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity
Debra L. Ellies et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors
Stephen J. Rodda et al.
DEVELOPMENT (2006)
Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation
Nan Zhong et al.
BONE (2006)
A Wnt canon orchestrating osteoblastogenesis
C Hartmann
TRENDS IN CELL BIOLOGY (2006)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation
MR Rickels et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes
TP Hill et al.
DEVELOPMENTAL CELL (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
The role of Axin2 in calvarial morphogenesis and craniosynostosis
HMI Yu et al.
DEVELOPMENT (2005)
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney
M Yanagita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6
SL Holmen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis
C Kokubu et al.
DEVELOPMENT (2004)
The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice
OG Kelly et al.
DEVELOPMENT (2004)
Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex
S Mercurio et al.
DEVELOPMENT (2004)
Wise, a context-dependent activator and inhibitor of Wnt signalling
N Itasaki et al.
DEVELOPMENT (2003)
Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity
N Kusu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling
BV Latinkic et al.
DEVELOPMENT (2003)
High bone mass in mice expressing a mutant LRP5 gene
P Babij et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
L Van Wesenbeeck et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
T Fujino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot
J Laurikkala et al.
DEVELOPMENTAL BIOLOGY (2003)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
M Kato et al.
JOURNAL OF CELL BIOLOGY (2002)
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
RD Little et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
